Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

T. P. O'Brien

doi:10.1185/030079905X50651

Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

T. P. O'Brien

Research output: Contribution to journal › Review article › peer-review

92 Scopus citations

Abstract

This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

Original language	English (US)
Article number	3044
Pages (from-to)	1131-1137
Number of pages	7
Journal	Current Medical Research and Opinion
Volume	21
Issue number	7
DOIs	https://doi.org/10.1185/030079905X50651
State	Published - Jul 2005
Externally published	Yes

Keywords

Cataract treatment strategy
Cystoid macular edema
Nonsteroidal antiinflammatory drugs

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1185/030079905X50651

Fingerprint Dive into the research topics of 'Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care'. Together they form a unique fingerprint.

Cite this

@article{0819d51a064541afa2727c8747308138,

title = "Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care",

abstract = "This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.",

keywords = "Cataract treatment strategy, Cystoid macular edema, Nonsteroidal antiinflammatory drugs",

author = "O'Brien, {T. P.}",

year = "2005",

month = jul,

doi = "10.1185/030079905X50651",

language = "English (US)",

volume = "21",

pages = "1131--1137",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",

publisher = "Informa Healthcare",

number = "7",

}

TY - JOUR

T1 - Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

AU - O'Brien, T. P.

PY - 2005/7

Y1 - 2005/7

N2 - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

AB - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

KW - Cataract treatment strategy

KW - Cystoid macular edema

KW - Nonsteroidal antiinflammatory drugs

UR - http://www.scopus.com/inward/record.url?scp=22744455811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22744455811&partnerID=8YFLogxK

U2 - 10.1185/030079905X50651

DO - 10.1185/030079905X50651

M3 - Review article

C2 - 16004683

AN - SCOPUS:22744455811

VL - 21

SP - 1131

EP - 1137

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 7

M1 - 3044

ER -